Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1bf3e008c4ff31c5f042f50649af41b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2519a8a24265d332d553ed57391f8a49 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f81a81d19a1b9e885793b8e4bb94f4 |
publicationDate |
2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8652488-B2 |
titleOfInvention |
Insulin B chain autoantigen composition |
abstract |
The invention features methods for the prevention or treatment of autoimmune disorders in humans. The methods include administering an autoantigen in combination with an oil-based carrier. Included are methods for the prevention and treatment of diabetes mellitus which include treating a patient with a diabetes type 1 autoantigen, e.g., human insulin B-chain or GAD65, and an oil-based carrier approved for human use. Also included are vaccines and kits for the treatment of diabetes mellitus. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014220015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286303-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233242-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040093-B2 |
priorityDate |
2001-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |